Holen Sie sich die Stockscreener-App
6.59
1.35%
-0.14
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
36.55%
0.1636
|
0.2579 | 0.00195 | - | 3.4253 |
| Operating Expenses |
17.10%
6.5781
|
7.9348 | 4.0822 | 4.4503 | 6.6614 |
| Benefits Costs and Expenses |
17.27%
6.2586
|
7.5646 | 3.638 | 4.0214 | - |
| Costs And Expenses |
17.27%
6.2586
|
7.5646 | 3.638 | 4.0214 | 6.6614 |
| Operating Income/Loss |
16.44%
-6.4145
|
-7.6769 | -4.0803 | -4.4503 | -3.2361 |
| Income/Loss From Continuing Operations Before Tax |
16.58%
-6.095
|
-7.3068 | -3.6361 | -4.0214 | -2.8917 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
16.58%
-6.095
|
-7.3068 | -2.9158 | -4.0214 | -2.8917 |
Net Income/Loss
|
16.58%
-6.095
|
-7.3068 | -2.9158 | -4.0214 | -2.8917 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.03%
16.72
|
16.72 | 0.3728 | 15.22 | 14.92 |
| Diluted Average Shares |
0.03%
16.72
|
16.72 | 0.3728 | 15.22 | 14.92 |
| Basic Earnings Per Share |
18.18%
-0.36
|
-0.44 | -0.18 | -0.26 | -0.19 |
| Diluted Earnings Per Share |
18.18%
-0.36
|
-0.44 | -0.18 | -0.26 | -0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.04%
7.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):